New hope for breast cancer patients: drug cuts hot flashes without hormones

NCT ID NCT06440967

First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 18 times

Summary

This study tests fezolinetant, a non-hormonal drug, for treating hot flashes in women with hormone-positive breast cancer who are on hormone therapy. About 984 women will take either fezolinetant or a placebo daily for a year. The goal is to see if the drug reduces how often and how severe hot flashes are, improving quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOT FLASHES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Site CA15001

    Québec, Quebec, Canada

  • Site CA15002

    Montreal, Quebec, Canada

  • Site CA15003

    Sherbrooke, Quebec, Canada

  • Site CA15004

    Québec, Quebec, Canada

  • Site CA15007

    Trois-Rivières, Canada

  • Site CA15016

    Sault Ste. Marie, Ontario, Canada

  • Site CA15019

    Sarnia, Ontario, Canada

  • Site CA15020

    Victoriaville, Quebec, Canada

  • Site CZ42001

    Olomouc, Czechia

  • Site CZ42002

    Hradec Králové, Czechia

  • Site CZ42003

    Hořovice, Czechia

  • Site CZ42004

    Tábor, Czechia

  • Site CZ42005

    Prague, Czechia

  • Site CZ42006

    České Budějovice, Czechia

  • Site CZ42007

    Vodňany, Czechia

  • Site CZ42008

    Prague, Czechia

  • Site CZ42009

    Vsetín, Czechia

  • Site CZ42011

    Nový Jičín, Czechia

  • Site CZ42013

    Prague, Czechia

  • Site DE45003

    Esbjerg, Denmark

  • Site DE45008

    Sønderborg, Denmark

  • Site DE49001

    Bottrop, Germany

  • Site DE49007

    Mönchengladbach, Germany

  • Site DE49009

    Leipzig, Germany

  • Site DE49010

    München, Germany

  • Site DK45002

    Næstved, Denmark

  • Site DK45007

    Aalborg, Denmark

  • Site DK45009

    Hillerød, Denmark

  • Site ES34002

    Murcia, Spain

  • Site ES34003

    Girona, Spain

  • Site ES34005

    Granada, Spain

  • Site ES34006

    Jaén, Spain

  • Site ES34007

    Madrid, Spain

  • Site ES34008

    Palma, Spain

  • Site ES34009

    Seville, Spain

  • Site ES34010

    Elche, Spain

  • Site ES34011

    Barcelona, Spain

  • Site ES34013

    Valencia, Spain

  • Site ES34014

    Murcia, Spain

  • Site ES34015

    Majadahonda, Spain

  • Site ES34017

    León, Spain

  • Site ES34019

    Madrid, Spain

  • Site ES34020

    Barcelona, Spain

  • Site ES34022

    Madrid, Spain

  • Site ES34023

    Madrid, Spain

  • Site ES34024

    Seville, Spain

  • Site ES34025

    Rivas-Vaciamadrid, Spain

  • Site FR33001

    Bayonne, France

  • Site FR33002

    Saint-Herblain, France

  • Site FR33003

    Angers, France

  • Site FR33005

    Bordeaux, France

  • Site FR33007

    Lille, France

  • Site FR33008

    Montpellier, France

  • Site FR33012

    Lyon, France

  • Site FR33013

    Le Mans, France

  • Site FR33016

    Dijon, France

  • Site FR33017

    Caen, France

  • Site FR33018

    Bordeaux, France

  • Site GB44001

    Preston Lancashire, United Kingdom

  • Site GB44002

    Liverpool, United Kingdom

  • Site GB44003

    Bristol, United Kingdom

  • Site GB44005

    London, United Kingdom

  • Site GB44006

    Glasgow, United Kingdom

  • Site GB44008

    Bebington, Birkenhead, United Kingdom

  • Site GB44009

    Guildford, Surrey, United Kingdom

  • Site GB44010

    Stroke on Trent, United Kingdom

  • Site GB44012

    Redhill, United Kingdom

  • Site GB44016

    Cambridge, United Kingdom

  • Site GB44017

    Oxford, United Kingdom

  • Site GB44018

    Aberdeen, United Kingdom

  • Site GB44019

    Birmingham, United Kingdom

  • Site GB44020

    Liverpool, United Kingdom

  • Site GR49003

    Münster, Germany

  • Site GR49005

    Essen, North Rhine-Westphalia, Germany

  • Site GR49013

    Dresden, Germany

  • Site GR49014

    Wolfsburg, Germany

  • Site HU36001

    Eger, Hungary

  • Site HU36002

    Kecskemét, Hungary

  • Site HU36003

    Székesfehérvár, Hungary

  • Site HU36006

    Debrecen, Hungary

  • Site HU36008

    Budapest, Hungary

  • Site HU36010

    Salgótarján, Hungary

  • Site IT39003

    Milan, Italy

  • Site IT39011

    Bologna, Italy

  • Site IT39012

    Terni, Italy

  • Site IT39013

    Mirano, Italy

  • Site IT39015

    Genova, Italy

  • Site IT39017

    Pavia, Italy

  • Site IT39018

    Reggio Emilia, Italy

  • Site NL31001

    Haarlem, Netherlands

  • Site NL31002

    Rotterdam, Netherlands

  • Site NL31004

    Rotterdam, Netherlands

  • Site NL31006

    Dirksland, Netherlands

  • Site NL31009

    Terneuzen, Netherlands

  • Site NL31010

    Breda, Netherlands

  • Site NL31012

    Rotterdam, Netherlands

  • Site PO48001

    Warsaw, Poland

  • Site PO48002

    Poznan, Poland

  • Site PO48003

    Świdnik, Poland

  • Site PO48004

    Katowice, Poland

  • Site PO48005

    Bialystok, Poland

  • Site PO48006

    Bydgoszcz, Poland

  • Site PO48007

    Lodz, Poland

  • Site PO48010

    Szczecin, Poland

  • Site PO48012

    Lodz, Poland

  • Site PO48015

    Krakow, Poland

  • Site PO48017

    Katowice, Poland

  • Site PO48018

    Poznan, Poland

  • Site PO48019

    Poznan, Skorzewo, Poland

  • Site PO48021

    Krakow, Poland

Conditions

Explore the condition pages connected to this study.